CFC-Free Inhalers Would Not Need To Replace All Strengths – FDA Final Rule
Executive Summary
CFC-free products would not need to replace all the strengths of multiple-strength, CFC-containing metered dose inhalers before FDA phases-out the CFC products, the agency says in a final rule
You may also be interested in...
Albuterol Transition To CFC-Free: Increased Cost Could Affect Patient Access
Increases in cost of albuterol inhalers due to the transition from chlorofluorocarbons to non-ozone depleting substances could affect patient access, members of FDA's Pulmonary-Allergy Drugs Advisory Committee suggested
Albuterol Transition To CFC-Free: Increased Cost Could Affect Patient Access
Increases in cost of albuterol inhalers due to the transition from chlorofluorocarbons to non-ozone depleting substances could affect patient access, members of FDA's Pulmonary-Allergy Drugs Advisory Committee suggested
Albuterol CFC Phase-Out Date Needed Now For HFA Ramp Up, Firms Says
A lack of a definitive date for the phase-out of chlorofluorocarbon propelled albuterol metered dose inhalers could delay ramp up of production of inhalers that use non ozone depleting substances, manufacturers suggested at the June 10 meeting of FDA's Pulmonary-Allergy Drugs Advisory Committee